Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Explore Funding Opportunities
    • How to Apply
    • Our Review Process
    • Manage Your Award
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Explore Funding Opportunities
    • How to Apply
    • Our Review Process
    • Manage Your Award
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Hematopoietic Stem Cell Gene Therapy for Alpha Thalassemia

  • Post author:
  • Post published:October 18, 2026
  • Post category:

Research Objective The objective of this research is to define the final therapeutic candidate for effective hematopoietic stem cell gene therapy to treat severe alpha thalassemia that requires life-ling transfusions…

Continue ReadingHematopoietic Stem Cell Gene Therapy for Alpha Thalassemia

Targeted Immunotherapy-Based Blood Stem Cell Transplantation

  • Post author:
  • Post published:October 18, 2026
  • Post category:

Research Objective An engineered antibody construct that targets and recruits immune cells to kill diseased blood stem cells, including leukemia stem cells, so that healthy stem cells can replace the…

Continue ReadingTargeted Immunotherapy-Based Blood Stem Cell Transplantation

Small Molecules to inhibit Nemo-like Kinase for Treatment of Diamond Blackfan Anemia

  • Post author:
  • Post published:October 18, 2026
  • Post category:

Research Objective We propose to study small molecules that inhibit Nemo-like Kinase, to improve the production of red blood cells in bone marrow stem cells of children with Diamond Blackfan…

Continue ReadingSmall Molecules to inhibit Nemo-like Kinase for Treatment of Diamond Blackfan Anemia

Hematopoietic Stem Cell Gene Therapy for X-linked Agammaglobulinemia

  • Post author:
  • Post published:October 18, 2026
  • Post category:

Research Objective The objectives of this study are to advance a stem cell gene therapy for the immunodeficiency XLA, defining the final therapeutic candidate and showing therapeutic activity in a…

Continue ReadingHematopoietic Stem Cell Gene Therapy for X-linked Agammaglobulinemia

Genome Editing of Sinusoidal Endothelial Stem Cells for Permanent Correction of Hemophilia A

  • Post author:
  • Post published:October 18, 2026
  • Post category:

Research Objective Therapeutic candidate to cure hemophilia A is AAV-based genome editing vector that corrects the disease-causing mutation in the factor VIII gene in patient stem cells to develop a…

Continue ReadingGenome Editing of Sinusoidal Endothelial Stem Cells for Permanent Correction of Hemophilia A

Targeted Gene Editing in the Treatment of X-Linked Hyper-IgM Syndrome

  • Post author:
  • Post published:October 18, 2026
  • Post category:

Research Objective We are seeking to develop site-specific hematopoietic stem cell gene therapy with autologous transplant as a definitive treatment option for X-linked Hyper-IgM Syndrome. Impact These studies would bring…

Continue ReadingTargeted Gene Editing in the Treatment of X-Linked Hyper-IgM Syndrome

Protein tyrosine phosphatase – sigma inhibitors for hematopoietic regeneration

  • Post author:
  • Post published:October 18, 2026
  • Post category:

Research Objective We propose to develop a lead small molecule inhibitor of PTPσ, a receptor expressed by human blood stem cells, for the purpose of promoting human hematopoietic regeneration. Impact…

Continue ReadingProtein tyrosine phosphatase – sigma inhibitors for hematopoietic regeneration

GENE EDITING FOR FOXP3 IN HUMAN HSC

  • Post author:
  • Post published:October 18, 2026
  • Post category:

Research Objective CRISPR/Cas9 mediated FOXP3 gene editing in patient-derived hematopoietic stem cells as a cure for IPEX syndrome Impact FOXP3 mutation in IPEX syndrome leads to immune system dysregulation. Allogeneic…

Continue ReadingGENE EDITING FOR FOXP3 IN HUMAN HSC

Optimizing self-renewal signaling kinetics to stabilize ex vivo hematopoietic stem cell expansion

  • Post author:
  • Post published:October 18, 2026
  • Post category:

Research Objective We aim to develop conditions for stable expansion of blood stem cells outside of the body Impact Blood stem cells are a rare but necessary cell type for…

Continue ReadingOptimizing self-renewal signaling kinetics to stabilize ex vivo hematopoietic stem cell expansion

Reprogramming human stem cells for blood cell generation

  • Post author:
  • Post published:October 18, 2026
  • Post category:

Research Objective To create a universal donor blood cell line that can be used to produce human red blood cells for transplantation. Impact Successful completion of this work would create…

Continue ReadingReprogramming human stem cells for blood cell generation
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 12
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us